• Caner Ediz, Hasan Huseyin Tavukcu, Serkan Akan, Yunus Emre Kizilkan, Adem Alcin, Kerem Oz, and Omer Yilmaz.
• Department of Urology, Sultan Abdulhamid Han Education and Research Hospital, Istanbul, Turkey.
• Int. J. Clin. Pract. 2021 Mar 1; 75 (3): e13753.

AimsThis study aims to analyse the novel Coronavirus disease- (COVID-19) related testicular pain in hospitalised patients because of COVID-19 and to review as an aetiological factor for epididymitis, orchitis or both.MethodsA total of 91 patients were included in the study. A questionnaire was formed for the questioning of testicular pain or epididymo-orchitis in patients with COVID-19. Demographics and past medical history was also recorded. Patients' neutrophil and lymphocyte counts, neutrophil-lymphocyte ratios (NLR), C-reactive protein (CRP) levels and D-dimer values were recorded. Patients with COVID-19 were divided into two groups according to absence or presence of testicular pain or epididymo-orchitis as group 1 and group 2. All results were compared for both groups.ResultsThe median age of patients was similar in both groups. Testicular pain was occurred in 10.98% of the patients. Clinical presentation of epididymo-orchitis was diagnosed in only one patient. No statistically significant difference was reported in terms of patients' age, levels of CRP and D-Dimer or NLR and results of questionnaire form queries between the two groups (P > .05).ConclusionTesticular pain was observed more frequently in hospitalised COVID-19 cases. While no inflammation marker which is related to predict of testicular pain or epididymo-orchitis was found in patients with COVID-19.© 2020 John Wiley & Sons Ltd.

10 keywords...

hide…